Australia markets closed

BARD1 Life Sciences Limited (BD1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0310-0.0010 (-3.13%)
At close: 3:52PM AEST
Currency in AUD

Valuation measures

Market cap (intra-day) 574.23M
Enterprise value 333.68M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)124.11
Price/book (mrq)5.17
Enterprise value/revenue 356.32
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (5Y monthly) -1.54
52-week change 33.33%
S&P500 52-week change 315.36%
52-week high 30.0560
52-week low 30.0190
50-day moving average 30.0305
200-day moving average 30.0280

Share statistics

Avg vol (3-month) 32.59M
Avg vol (10-day) 35.74M
Shares outstanding 52.39B
Float 1.08B
% held by insiders 137.29%
% held by institutions 111.36%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 311 Sep 2008

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2019
Most-recent quarter (mrq)31 Dec 2019

Profitability

Profit margin 0.00%
Operating margin (ttm)-403.97%

Management effectiveness

Return on assets (ttm)-24.19%
Return on equity (ttm)-41.52%

Income statement

Revenue (ttm)598.1k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)98.40%
Gross profit (ttm)-142.78k
EBITDA N/A
Net income avi to common (ttm)-2.4M
Diluted EPS (ttm)-0.0020
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.7M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)16.61
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-1.91M
Levered free cash flow (ttm)-1.03M